Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The weight loss medications on the market today are generally approved ... cocktails of appetite suppressants known as “rainbow pills” were heavily marketed to American women.

Three years later, the weight loss ... the market have prompted other pharmas to develop similar therapies, some with potentially less severe side effects and more convenient dosing. The best ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon ... Morgan Stanley (MS) analysts anticipate the global market for the highly coveted treatments ...

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better ... the existing drugs on the market have to be injected rather than ...